解决无氧性皮肤炎的未满足需求:评估当前和新兴疗法的疾病修饰能力
Sarah G Brooks1, Lourdes M Lopez1, Kayla D Mashoudy1
1From the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Coral Gables, Florida, USA.
Dermatitis : contact, atopic, occupational, drug
|October 28, 2024
概括
亚托皮炎 (AD) 管理需要新的策略,而不仅仅是暂时缓解症状. 对内型特异性治疗和微生物组,免疫和神经功能操纵的研究表明,对长期疾病修饰有希望.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亚托邦性皮肤炎 (AD) 是一种流行的炎症性皮肤疾病,影响儿童和成人.
- 目前的全身疗法提供了暂时的缓解,但往往无法控制复发的AD.
- 在药物限制之外的AD治疗中存在重大未满足的需求.
研究的目的:
- 审查关于AD治疗的当前文献,确定未满足的需求.
- 评估现有的疗法是否能够改变潜在的疾病机制.
- 探索长期AD管理的新型治疗方法.
主要方法:
- 系统的文学综合.
- 分析当前的治疗选择及其有效性.
- 识别新出现的治疗策略.
主要成果:
- 阿尔茨海默症的病理生理学和表型在不同年龄组和种族之间有很大差异.
- 向生物制剂和简氏激酶 (JAK) 抑制剂显示出长期疾病修饰的潜力.
- 针对微生物组,免疫和神经通路的新方法正在出现.
结论:
- 对于有效的AD管理,需要进行内型特异性治疗.
- 目前的先进疗法可能提供疾病修饰的好处.
- 未来的战略应该整合微生物组,免疫和神经调制,以改善结果.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
246
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
246
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
143
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
143
Inflammatory Bowel Disease IV: Pharmacological Management
117
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
117
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
240
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
240
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
97
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
97
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39


